Brief: Sequana Medical: Positive Pre-Clinical And Clinical Proof-Of-Concept Data On Its DSR Therapy
Jan 10 (Reuters) - Sequana Medical NV SEQUA.BR :
* SEQUANA MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA OF DIRECT
SODIUM
REMOVAL (DSR) THERAPY PUBLISHED IN CIRCULATION
* DATA DEMONSTRATES POTENTIAL FOR TREATMENT OF VOLUME
OVERLOAD DUE
TO HEART FAILURE
* POSITIVE PRE-CLINICAL AND CLINICAL PROOF-OF-CONCEPT DATA
OF
SEQUANA MEDICAL'S INNOVATIVE DSR THERAPY
Source text for Eikon: ID:nGNE51RHXq
Further company coverage: SEQUA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Sequana Medical NV
See all newsAdvisory: Alert wrongly tagged to Decision Diagnostics withdrawn
Brief: Sequana Medical Board Resolves To File For Bankruptcy With Ghent Enterprise Court
Brief: Sequana Medical H1 Revenue EUR 106 Thousand
Brief: Sequana Medical H1 Revenue EUR 106 Thousand
Brief: Sequana Medical FY EBIT EUR -28.862 Million